Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with high morbidity and mortality worldwide. Chemotherapy is recommended to patients with intermediate or advanced stage cancer. However, the conventional chemotherapy yields low desired response rates due to multidrug resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Min, Zhang, Weiyue, Wang, Birong, Gao, Yang, Song, Zifang, Zheng, Qi Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127222/
https://www.ncbi.nlm.nih.gov/pubmed/27920520
http://dx.doi.org/10.2147/IJN.S115727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127222/
https://www.ncbi.nlm.nih.gov/pubmed/27920520
http://dx.doi.org/10.2147/IJN.S115727

Ejemplares similares